|
FDA Tough on Cell Therapeutics' Drug
Last week, I laid out in detail seven reasons why the U.S.
Food and Drug Administration could decide to reject Cell
Therapeutics' lymphoma drug pixantrone.
2/8/2010 12:24 PM EST
Thain's Massive Pay Cut
What a difference a crisis makes for CIT Group's new boss,
John Thain. In 2010, Thain will likely make less than 10%
of the $83.1 million he took home at Merrill Lynch in 2007,
when he earned more than any other CEO of an S&P 500
company, according to a 2008 Associated Press study.
2/8/2010 1:43 PM EST
Regionals Get a Clue on Capital Ratios
The recent equity raise by PNC Financial Services as part
of its plan to repay bailout funds potentially provides a
valuable clue about what capital standards regulators will
eventually adopt.
2/8/2010 12:06 PM EST
Seven Surprising ETFs of 2010
With just over a month in the books for 2010, equity
markets have already been taken on a wild ride. After an
initial jump, concerns over a government-imposed slowdown
in China weighed on global stocks, particularly emerging
markets and commodity-intensive businesses.
2/8/2010 11:42 AM EST
Gold Prices Headed to $820 an Ounce?
Gold price forecasts are all over the map. Citi analyst
Alan Heap adds a bearish voice to a more bullish chorus.
Take a look at the bull and bear cases, then tell us what
you think in our poll.
2/8/2010 1:07 PM EST
Seanergy, Borders: Midday Volume Plays
Several stocks trading near $5 were moving on above-average
volume during Monday's session.
2/8/2010 1:18 PM EST
Sponsored Links
|
